Skip to main navigation menu Skip to main content Skip to site footer

Original article

Vol. 151 No. 3334 (2021)

Management and outcomes of patients on maintenance dialysis during the first and second wave of the COVID-19 pandemic in Geneva, Switzerland 

  • Ido Zamberg
  • Thomas Mavrakanas
  • Thomas Ernandez
  • Vincent Bourquin
  • Michael Zellweger
  • Nicolas Marangon
  • Françoise Raimbault
  • Rebecca Winzeler
  • Anne Iten
  • Nathalie Hammer
  • Belen Ponte
  • Sebastian Carballo
  • Pierre-Yves Martin
  • Patrick Saudan
Cite this as:
Swiss Med Wkly. 2021;151:w30006


BACKGROUND: Patients on maintenance dialysis are at high risk for serious complications from COVID-19 infection, including death. We present an overview of local experience with dialysis unit management and reorganisation, local epidemiology and outcomes during the COVID-19 outbreak in Geneva, Switzerland, where SARS-CoV-2 incidence was one of the highest in Europe.

METHODS: All SARS-CoV-2-positive outpatients on maintenance dialysis were transferred from their usual dialysis facility to the Geneva University Hospitals dialysis unit to avoid creation of new clusters of transmission. Within this unit, appropriate mitigation measures were enforced, as suggested by the institutional team for prevention and control of infectious diseases.

RESULTS: From 25 February to 31 December 2020, 82 of 279 patients on maintenance dialysis tested positive for SARS-CoV-2 during two distinct waves, with an incidence rate of 73 cases per 100,000 person-days during the first wave and 342 cases per 100,000 during the second wave, approximately four- to six-fold higher than the general population. The majority of infections (55%) during both waves were traced to clusters. Most infections (62%) occurred in men. Sixteen patients (34%) died from COVID-19 related complications. Deceased patients were older and had a lower body mass index as compared with patients who survived the infection.

CONCLUSION: SARS-CoV-2 is associated with high infection and fatality rates in the dialysis population. Strict mitigation measures seemed to be effective in controlling infection spread among patients on maintenance dialysis outside of clusters. Large scale epidemiological studies are needed to assess the efficacy of preventive measures in decreasing infection and mortality rates within the dialysis population.


  1. WHO. WHO announces COVID-19 outbreak a pandemic. 2020.
  2. WHO. (2021, March 18). WHO Coronavirus Disease (COVID-19) Dashboard.
  3. Fisher D, Heymann D. Q&A: the novel coronavirus outbreak causing COVID-19. BMC Med. 2020 Feb;18(1):57.
  4. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239.
  5. Sohrabi C, Alsafi Z, O’Neill N, Khan M, Kerwan A, Al-Jabir A, et al. World Health Organization Declares Global Emergency: A Review of the 2019 Novel Coronavirus (COVID-19). Int J Surg. 2020;76:71-76. 10.1016/j.ijsu.2020.02.034.
  6. do Sameiro-Faria M, Ribeiro S, Costa E, Mendonça D, Teixeira L, Rocha-Pereira P, et al. Risk factors for mortality in hemodialysis patients: two-year follow-up study. Dis Markers. 2013;35(6):791–8.
  7. Jordan RE, Adab P, Cheng KK. Covid-19: risk factors for severe disease and death. BMJ.2020;368:m1198. 10.1136/bmj.m1198.
  8. @robinlayfield: Global Covid-19 Case Fatality Rates - CEBM. 2020.
  9. Weiner DE, Watnick, SG. Hemodialysis and COVID-19: An Achilles’ Heel in the Pandemic Healthcare Response in the United States. Kidney Med. 2020;2(3):227-30. doi: 10.1016/j.xkme.2020.03.004.
  10. The Swiss Academy for Medical Sciences : Intensive care medicine: triage in case of bottlenecks. & Privacy Policy, 2020.
  11. Beddhu S, Bruns FJ, Saul M, Seddon P, Zeidel ML. A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. Am J Med. 2000 Jun;108(8):609–13.
  12. Federal Office of Public Health : New coronavirus: Current situation – Switzerland and international. 2020.
  13. Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: estimation and Application. Ann Intern Med. 2020 May;172(9):577–82.
  14. RECOVERY Collaborative Group, Horby P, Lim WS, et al. Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report [published online ahead of print, 2020 Jul 17]. N Engl J Med. 2021;384(8):693–704.
  15. Chandel A, Patolia S, Brown AW, et al. High-flow nasal cannula in COVID-19: Outcomes of application and examination of the ROX index to predict success [published online ahead of print, 2020 Dec 16]. Respir Care. 2021;66(6):909–19. doi:
  16. Meijers B, Messa P, Ronco C. Safeguarding the Maintenance Hemodialysis Patient Population during the Coronavirus Disease 19 Pandemic. Blood Purif. 2020;49(3):259–64.
  17. Alberici F, Delbarba E, Manenti C, Econimo L, Valerio F, Pola A, et al. Management Of Patients On Dialysis And With Kidney Transplant During SARS-COV-2 (COVID-19) Pandemic In Brescia, Italy. Kidney Int Rep. 2020;5(5):580–5. 10.1016/j.ekir.2020.04.001
  18. Alberici, F, Delbarba, E, Manenti, C, Econimo, L, Valerio, F, Pola, A, et al. : A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection. Kidney Int. 2020 Jul;98(1):20–6. 10.1016/j.kint.2020.04.030
  19. Goicoechea M, Cámara LAS, Marañón, Muñoz de Morales  A, González Rojas a, Bascuñana A,  et al. COVID-19: Clinical course and outcomes of 36 maintenance hemodialysis patients from a single center in Spain. Kidney Int. 2020;8(1):27–34.10.1016/j.kint.2020.04.031
  20. De Meester J, De Bacquer D, Naesens M, Meijers B, Couttenye MM, De Vriese AS ; NBVN Kidney Registry Group. Incidence, Characteristics, and Outcome of COVID-19 in Adults on Kidney Replacement Therapy: A Regionwide Registry Study. J Am Soc Nephrol. 2021 Feb;32(2):385–96.
  21. Hsu CM, Weiner DE, Aweh G, et al. COVID-19 Infection Among US Dialysis Patients: Risk Factors and Outcomes From a National Dialysis Provider [published online ahead of print, 2021 Jan 16]. Am J Kidney Dis. 2021;S0272-6386(21)00025-1. doi:
  22. Jialin W, Yi Z, Weijie Y. Relationship between body mass index and mortality in hemodialysis patients: a meta-analysis. Nephron Clin Pract. 2012;121(3-4):c102–11.
  23. @CDCgov: Considerations for Providing Hemodialysis to Patients with Suspected or Confirmed COVID-19 in Acute Care Settings | CDC. 2020.
  24. NICE : Overview | COVID-19 rapid guideline: dialysis service delivery | Guidance | NICE. 2020.
  25. Kliger, AS, Silberzweig, J : Mitigating Risk of COVID-19 in Dialysis Facilities. 2020.
  26. Watnick S, McNamara E. Keeping Patients on Long-Term Dialysis Safe. Clin J Am Soc Nephrol. 2020 May 7;15(5):710–13. 10.2215/CJN.03540320

  27. Mokrzycki MH, Coco M Management of hemodialysis patients with suspected or confirmed COVID-19 infection: perspective of two nephrologists in the United States. Kidney360. 2020;1(4):273–8. 10.34067/KID.0001452020.
  28. Ikizler TA. COVID-19 and Dialysis Units: What Do We Know Now and What Should We Do? Am J Kidney Dis. 2020 Jul;76(1):1–3.
  29. Li C, Romagnani P, von Brunn A, Anders HJ. SARS-CoV-2 and Europe: timing of containment measures for outbreak control. Infection. 2020;48(3):483–6. 10.1007/s15010-020-01420-9
  30. @CDCgov: Evaluation of the Effectiveness of Surveillance and Containment Measures for the First 100 Patients with COVID-19 in Singapore — January 2–February 29, 2020 | MMWR. 2020.

Most read articles by the same author(s)